References
- Ahmed W, Orasanu G, Nehra V, Asattyan L, Rader DJ, Ziouzenkova O, Plutzky J. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res. 2006. 98: 490-498. https://doi.org/10.1161/01.RES.0000205846.46812.be
- Algenstaedt P, Schaefer C, Biermann T, Hamann A, Schwarzloh B, Greten H, Ruther W, Hansen-Algenstaedt N. Microvascular alterations in diabetic mice correlate with level of hyperglycemia Diabetes 2003.52: 542-549.
- Bancells C, Sanchez-Quesada JL, Birkelund R, Ordonez-Llanos J, Benitez S. HDL and electronegative LDL exchange anti- and pro-inflammatory properties. J Lipid Res. 2010. 51: 2947-2956. https://doi.org/10.1194/jlr.M005777
- Benitez S, Camacho M, Bancells C, Vila L, Sanchez-Quesada JL, Ordonez-Llanos J. Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta. 2006. 1761: 1014-1021. https://doi.org/10.1016/j.bbalip.2006.03.020
- Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 2003. 107: 2102-2108. https://doi.org/10.1161/01.CIR.0000065220.70220.F7
- de Jong SC, Stehouwer CD, van den Berg M, Vischer UM, Rauwerda JA, Emeis JJ. Endothelial marker proteins in hyperhomocysteinemia. Thromb Haemost. 1997. 78: 1332-1337.
- Dickstein K, Aarsland T, Hall C. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure. J Card Fail. 1997.3: 83-89. https://doi.org/10.1016/S1071-9164(97)90039-7
- Ford ES, Giles WH, Mokdad AH. The distribution of 10-Year risk for coronary heart disease among US adults: findingw from the National Health and Nutrition Examination Survey III. J Am Coli Cardiol. 2004. 43: 1791-1796. https://doi.org/10.1016/j.jacc.2003.11.061
- Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, Gottschall CA. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J. 2010. 51: 86-91. https://doi.org/10.1536/ihj.51.86
- Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. Highdensity lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989. 79: 8-15. https://doi.org/10.1161/01.CIR.79.1.8
- Goswami B, Rajappa M, Singh B, Ray PC, Kumar S, Mallika V. Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease. Cardiovasc J Afr. 2010.21: 103-108.
- Hall ER, Martin SA, Suzuki JB, Falkler WA Jr. The gingival immune response to periodontal pathogens in juvenile periodontitis. Oral Microbiol lmmunol. 1994.9: 327-334. https://doi.org/10.1111/j.1399-302X.1994.tb00282.x
- Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K. Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol. 1992. 24: 579-584. https://doi.org/10.1016/0735-1097(94)90322-0
- Jax TW, Peters AJ, Plehn G, Schoebel FC. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Cardiovasc Diabetol. 2009. 8: 48. https://doi.org/10.1186/1475-2840-8-48
- Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991. 67: 1360-1367. https://doi.org/10.1016/0002-9149(91)90466-X
- Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med. 1986. 105: 221-233.
- Lee HS, Cheng QL, Thako NY. ECG waveform analysis by significant point extraction. I. Data reduction. Comput Biomed Res. 1987.20:410-427. https://doi.org/10.1016/0010-4809(87)90030-9
- Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998.339: 321-328. https://doi.org/10.1056/NEJM199807303390507
- Lowe GDO. Haemostatic risk factors for arterial and venous thrombosis. In: Poller L, Ludlam CA. eds. Recent advancesin blood coagulation, 7th edn. Edinburgh: Churchill Livingstone 1997.69-96.
- Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol. 2007. 137: 36-48.
- Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001. 134: 629-636. https://doi.org/10.7326/0003-4819-134-8-200104170-00007
- Medeiros LJ, Gelb AB, Weiss LM. Low-grade renal cell carcinoma. A clinicopathologic study of 53 cases. Am J Surg Pathol. 1987.11: 633-642. https://doi.org/10.1097/00000478-198708000-00007
- Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo 1999. 13: 295-309.
- Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol. 2005. 16: 507-511. https://doi.org/10.1097/01.mol.0000181325.08926.9c
- Schindhelm RK. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. Am J Gastroenterol. 2009. 104: 2857-2858. https://doi.org/10.1038/ajg.2009.498
- Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003. 107: 87-92. https://doi.org/10.1161/01.CIR.0000042700.48769.59
- Singh HS, Bibbins-Domingo K, Ali S, Wu AH, Schiller NB, Whooley MA. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study. Clin Cardiol. 2009.32: 447-453. https://doi.org/10.1002/clc.20569
- Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993. 16: 434-444. https://doi.org/10.2337/diacare.16.2.434
- Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000. 321: 405-412. https://doi.org/10.1136/bmj.321.7258.405
- Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G, Koehler E. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J. 2000. 21: 1000-1008. https://doi.org/10.1053/euhj.1999.1981
- True MW. Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine. J Diabetes Sci Technol. 2009. 3: 743-747.
- VanWijk MJ, VanBavel E, Sturk A, Nieuwland R Microparticles in cardiovascular diseases. Cardiovasc Res. 2003. 59: 277-287. https://doi.org/10.1016/S0008-6363(03)00367-5
- Watanabe S, Shite J, Takaoka J, Shinke T, Imuro Y, Ozawa T, Otake H, Matsumoto D, Ogasawara D, Paredes OL, Yokoyama M. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart 2006. 27: 832-838. https://doi.org/10.1093/eurheartj/ehi772
- Wojchowski DM, Menon MP, Sathyanarayana P, Fang J, Karur V, Houde E, Kapelle W, Bogachev O. Erythropoietin-dependent erythropoiesis: New insights and questions. Blood Cells Mol Dis. 2006. 36: 232-238. https://doi.org/10.1016/j.bcmd.2006.01.007